Biodegradable microspheres containing heparin in the treatment of proliferative vitreoretinopathy

刘瑜玲,陈改清,张强,徐亮,张士元,何蕾
2000-01-01
Abstract:Objective: To investigate the possibility of biodegradable heparin polylactic acid microspheres (HEP-MS) for the treatment of proliferative vitreoretinopathy (PVR) in an experimental rabbit model. Methods: Biodegradable microspheres containing heparin was prepared by solvent evaporation method. Morphology of HEP-MS was examined by the scanning electron microscope. The loading copacity of heparin in HEP-MS was analyzed by a fluorospectro-photometer, and the in vitro release of heparin from the HEP-MS was also investigated. Twenty pigmented rabbits (40 eyes) were divided into two groups. The blank microspheres (10 eyes) and phosphate buffer solution (PBS) (10 eyes) were injected intravitreally as the control. The HEP-MS containing 1.42 mg/ml(20 eyes) of HEP were injected into the other group. 7 d after second gas-compression vitrectomy, 2 x 105 fibroblastes and HEP-MS (or control) were injected into all eyes sequentially. The morbidity of tractional retinal detachment (TRD) were observed by ophthalmoscope for 4 weeks. Results: The HEP-MS was quite round, and the mean diameter of HEP-MS was 68.6 μm. The loading capacity of heparin in HEP-MS was 1.42%. 4 weeks later, the morbidity of TRD in control; 1.42 mg/ml HEP-MS group was 80% , and 50% respectively. Significant statistical difference was found between the control group and the HEP-MS group(P < 0. 05). Conclusion: The microspheres containing 1.42 mg/ml of HEP can inhibit the occurrence of TRD effectively.
What problem does this paper attempt to address?